Identification and management of invasive mycoses in internal medicine: a road-map for physicians
Open Access
- 29 May 2014
- journal article
- review article
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 9 (5) , 501-511
Abstract
Invasive mycoses are a rising problem, not only in traditional categories of patients like hematologic or neutropenic ones, but also in elderly non-neutropenic patients admitted to internal medicine wards. Patients being admitted to medical wards are usually older, have multiple comorbidities, e.g., liver cirrhosis or chronic obstructive respiratory disease, may be malnourished or receive peripheral or total parenteral nutrition, and frequently are undergoing chronic corticosteroid therapy, chemotherapy for cancer or monoclonal antibodies for autoimmune diseases. Such risk factors may be contemporarily present in a single patient increasing the risk for the development of invasive mycoses. Diagnosis of candidemia and invasive aspergillosis is particularly difficult in patients hospitalized on medical wards, since symptoms and signs have low specificity, and most diagnostic tests have been only validated in neutropenic hematologic patients, but not in those without neutropenia. Both candidemia and invasive aspergillosis carry significant morbidity and mortality. The aim of this paper is to provide a simple guide to physicians for a prompt identification and treatment of patients with possible or suspected invasive mycoses.Keywords
This publication has 70 references indexed in Scilit:
- ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patientsClinical Microbiology and Infection, 2012
- Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosisJournal of Antimicrobial Chemotherapy, 2010
- Detection of candidaemia in patients with and without underlying haematological diseaseClinical Microbiology and Infection, 2010
- Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patientsInternational Journal of Hematology, 2009
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2008
- Echinocandins for Candidemia in Adults without NeutropeniaNew England Journal of Medicine, 2006
- Efficacy of Galactomannan Antigen in the Platelia Aspergillus Enzyme Immunoassay for Diagnosis of Invasive Aspergillosis in Liver Transplant RecipientsJournal of Clinical Microbiology, 2004
- The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacyExpert Opinion on Investigational Drugs, 2003
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990The Journal of Infectious Diseases, 1993